N-苄氧羰基-4-[(3R)-3-氨基-1-氧-4-(苯硫基)丁基]吗啉结构式
|
常用名 | N-苄氧羰基-4-[(3R)-3-氨基-1-氧-4-(苯硫基)丁基]吗啉 | 英文名 | N-Benzyloxycarbonyl-4-[(3R)-3-amino-1-oxo-4-(phenylthio)butyl]morpholine |
|---|---|---|---|---|
| CAS号 | 870812-93-4 | 分子量 | 414.51800 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C22H26N2O4S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 中文名 | (1R)-3-(4-吗啉)-3-氧代-1-((苯基磺酰基)甲基)丙基氨基甲酸苄酯 |
|---|---|
| 英文名 | benzyl N-[(2R)-4-morpholin-4-yl-4-oxo-1-phenylsulfanylbutan-2-yl]carbamate |
| 英文别名 | 更多 |
| 分子式 | C22H26N2O4S |
|---|---|
| 分子量 | 414.51800 |
| 精确质量 | 414.16100 |
| PSA | 96.66000 |
| LogP | 3.46490 |
|
~74%
N-苄氧羰基-4-[(3R)-... 870812-93-4 |
| 文献:Elmore, Steven W.; Bruncko, Milan; Park, Cheol-Min Patent: US2005/272744 A1, 2005 ; Location in patent: Page/Page column 20 ; US 20050272744 A1 |
|
~46%
N-苄氧羰基-4-[(3R)-... 870812-93-4 |
| 文献:GENENTECH, INC.; WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH Patent: WO2008/61208 A2, 2008 ; Location in patent: Page/Page column 31; 33 ; WO 2008/061208 A2 |
|
~%
N-苄氧羰基-4-[(3R)-... 870812-93-4 |
| 文献:ASTRAZENECA AB Patent: US2012/35134 A1, 2012 ; |
|
~%
N-苄氧羰基-4-[(3R)-... 870812-93-4 |
| 文献:ASTRAZENECA AB Patent: US2012/35134 A1, 2012 ; |
|
~%
N-苄氧羰基-4-[(3R)-... 870812-93-4 |
| 文献:ASTRAZENECA AB Patent: US2012/35134 A1, 2012 ; |
|
~%
N-苄氧羰基-4-[(3R)-... 870812-93-4 |
| 文献:ASTRAZENECA AB Patent: US2012/35134 A1, 2012 ; |
| (R)-benzyl 4-morpholino-4-oxo-1-(phenylthio)butan-2-ylcarbamate |
| N-Benzyloxycarbonyl-4-[(3R)-3-amino-1-oxo-4-(phenylthio)butyl]morpholine |
| N-[(1R)-3-(4-Morpholinyl)-3-oxo-1-[(phenylthio)methyl]propyl]carbamic Acid Phenylmethyl Ester |
| benzyl (1R)-3-(4-morpholinyl)-3-oxo-1-((phenylsulfanyl)methyl)propylcarbamate |
| [(1R)-3-(4-Morpholinyl)-3-oxo-1-[(phenylthio)methyl]propyl]carbamic Acid Benzyl Ester |